China SXT PharmaceuticalsSXTC 
$0.65-5.51%24h
-5.51%24h
Global rank
Market cap$368.73K
Change 7d13.19%
YTD Performance-75.02%
SP500 benchmarkUnderperform
P/E0
P/S0.19
Revenue$1.97M
Earnings-$5.93M
Dividend yield-
Main Sector
Healthcare
Category
China SXT Pharmaceuticals SXTC Operating Margins
Operating Margin in 2022: -2.84%
According to China SXT Pharmaceuticals latest financial reports the company has an operating margin of -2.84%, an increase of 42.61% to 2022. At the end of 2022 company had an operating margin of -1.99%.
China SXT Pharmaceuticals Operating Margin from 2020 to 2024
-
Value:-
SXTC Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -2.84% | 42.61% |
| 2022 | -1.99% | 333.66% |
| 2021 | -0.46% | 77.02% |
| 2020 | -0.26% | - |
View the highest operating margin companies 
